Microsoft Appoints New Responsible Tech Lead Amid Tension Between AI Speed and Trustworthy Development Plus500 Revenue Jumps 11 in Latest Quarter Company Reaffirms Annual Outlook Hong Kongs Gold Hub Ambitions Get Boost with New Clearing System Set for July Launch Yaashvi Jewellers IPO Day 1 Sees Tepid Demand with 2 Subscription MongoDB Q1 Preview Wedbush Sees Upside on Atlas Growth and AI Momentum Wall Streets Mixed Outlook on IDEX Corporation Bullish and Bearish Signals Emerge NGG Q1 2026 Earnings EPS Falls Short of Estimates as Utility Giants Shares Edge Higher Nyxoah NYXH Q1 2026 Earnings NarrowerThanExpected Loss as PreRevenue Biotech Advances Sleep Apnea Pipeline VRTX Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick DARE Q1 2026 Earnings Narrowerthanexpected loss surprises as no revenue reported NioCorp Q1 2026 Earnings Surprise Profitability Achieved Amid PreRevenue Stage BWA Q1 2026 Earnings Earnings Per Share Surpasses Estimates Stock Rises Worksport WKSP Slides Over 8 as Stock Approaches Key Support Floor Imperial Petroleum IMPP Slides 184 Support Test as Crude Volatility Weighs on Energy Equities SeaStar Medical ICU Surges 627 as Stock Tests Key Resistance at 40 Graham Corporation GHM Rallies 25 Testing Key Resistance at 9971 JetBlue Airways JBLU Rises 227 Airline Stock Approaches Resistance at 567 Generative AI and ChatGPT Emerging Tools for Coping With Situational Depression ASLE Earnings Overview 20260527 Aon plc AON Holds Steady Near 325 as Insurance Broker Sector Maintains Resilience GBR Q3 2023 Earnings Minimal Earnings Reported as Stock Declines Amer Sports Q1 2026 Earnings EPS Beats Estimates by 211 Revenue Not Disclosed GENI Q1 2026 Earnings EPS Falls Short Yet Stock Surges 583 on Strategic Optimism Interactive Brokers Group Inc IBKR Q1 2026 Earnings EPS Falls Slightly Short of Estimates Amid Stable Trading Activity ATI Q1 2026 Earnings Strong EPS Surprise of 124 Outpaces Analyst Expectations Stock Edges Lower QuinStreet Q1 2026 Earnings EPS Miss But Stock Pushes Higher DMAC Q1 2026 Earnings Wider Loss Than Expected as Clinical Pipeline Advances